The Canadian patent system provides multiple post-grant administrative procedures that allow patentees and third parties to ...

Canada has implemented a Patent Term Adjustment (PTA) system to account for unreasonable delays by the Canadian Intellectual ...

Intellectual property protection is the lifeblood of any enterprise that creates value from ideas. In the biopharmaceutical industry, protecting our discoveries allows us to turn scientific research ...

OTTAWA, ON, Aug. 25, 2025 /CNW/ - Canada's intellectual property landscape reveals a mix of inventive strengths and weaknesses across 35 key technology areas, according to new research from The ...

The population of Canada is barely more than 10 percent of the population of the United States, and as such is mostly never considered in the list of countries in which an inventor wishes to patent an ...

Thepatent relates to methods of administering therapeutically effective amounts of isolated allogeneic mesenchymal stem cells (MSCs) to patients ...

The similarities Canada's IP regime shares many similarities with those of other countries. As with most countries, aside from the US, Canada has a first-to-file patent system in which a patent is ...

Canada is not the first country that comes to mind as a threat to U.S. trade. After all, Canada is our largest goods trading partner, with $632 billion in total goods traded bilaterally during 2013.

Following the signing of the Comprehensive Economic and Trade Agreement (CETA) with the European Union, the Government of Canada has amended Canada's pharmaceutical drug linkage regulations, the ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

SAN ANTONIO, July 22, 2025--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing early-stage cancer diagnostics including CyPath® Lung, the ...

TORONTO (Reuters) - Canada's emergency legislation on the coronavirus crisis gives the health minister powers to circumvent patent law and ensure medical supplies, medication or vaccines can be ...